透雲生物(01332.HK)訂立蒸汽管網資產轉讓協議
格隆匯7月31日丨透雲生物(01332.HK)發佈公告,於2025年7月31日,賣方(公司的間接全資附屬公司)(作爲賣方)與買方長治市潞城區潞新建設投資集團有限公司就出售位於山西省長治市潞城區的若幹蒸汽管道設施訂立蒸汽管網資產轉讓協議,代價爲人民幣1482萬元。
賣方向買方轉讓以下目標資產(i)發電廠內550米中壓蒸汽管道及420米冷凝水回收管道;及(ii)從發電廠至賣方位於中國山西省長治市潞城區店上鎮常莊村潞城經濟技術開發區的廠房邊界的1,550米中壓蒸汽管道、1,550米冷凝水回收管道及配套設施。
經考慮集團將收取的代價,董事會認爲,集團進行出售事項乃屬恰當。出售事項落實後,可加強集團的現金流量,使集團得以改善其流動資金,並讓集團可重新分配其資源作未來發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.